Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Izotropic Corp (IZO.CN)

Izotropic Corp (IZO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 20,598
  • Shares Outstanding, K 67,535
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,140 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2700 +12.96%
on 11/27/25
0.4250 -28.24%
on 11/10/25
-0.1250 (-29.07%)
since 11/05/25
3-Month
0.2700 +12.96%
on 11/27/25
0.4900 -37.76%
on 10/23/25
-0.0150 (-4.69%)
since 09/05/25
52-Week
0.0350 +771.43%
on 12/11/24
0.4900 -37.76%
on 10/23/25
+0.2500 (+454.55%)
since 12/05/24

Most Recent Stories

More News
Izotropic Launches Podcast Episode #2: AI and the Future of Breast Imaging: How Izotropic is Leading the Innovation

Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - November 12, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device...

IZO.CN : 0.3050 (unch)
IZOZF : 0.2213 (-0.49%)
Upcoming Meeting Dates - November 3, 2025

Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - The following is a list of Upcoming Meeting Dates for Reporting Issuers in Canada. The data is supplied by Issuing Companies through the service...

KEC.TO : 24.60 (-0.20%)
SUP.VN : 2.370 (-0.84%)
FMT.VN : 4.700 (-3.89%)
BARU.VN : 0.070 (unch)
SPN.VN : 0.050 (unch)
ESBL.VN : 0.170 (+6.25%)
GRDM.VN : 0.140 (-3.45%)
VGD.VN : 0.140 (+7.69%)
ESAU.CN : 0.7000 (+2.94%)
NTE.VN : 0.095 (-5.00%)
PRR.CN : 0.0700 (-6.67%)
BY.CN : 0.0350 (-12.50%)
Izotropic Launches "Breast Imaging News" Page on BreastCT.com

Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 28, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device...

IZO.CN : 0.3050 (unch)
IZOZF : 0.2213 (-0.49%)
Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...

IZO.CN : 0.3050 (unch)
IZOZF : 0.2213 (-0.49%)
Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market

EQNX::TICKER_START (OTCQB:IZOZF),(CSE:IZO),(NASDAQ:NVDA),(NYSE:BFLY),(NASDAQ:LNTH),(NASDAQ:RDNT) EQNX::TICKER_END

IZO.CN : 0.3050 (unch)
NVDA : 182.41 (-0.53%)
IZOZF : 0.2213 (-0.49%)
LNTH : 63.30 (+2.31%)
BFLY : 3.06 (unch)
RDNT : 78.59 (-3.07%)
Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook

Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 23, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device...

IZO.CN : 0.3050 (unch)
IZOZF : 0.2213 (-0.49%)
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...

IZO.CN : 0.3050 (unch)
IZOZF : 0.2213 (-0.49%)
CEO.CA's Inside the Boardroom: This Breast Cancer Tech by Izotropic Targets 50% of Women Currently Underserved

Toronto, Ontario--(Newsfile Corp. - October 21, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded...

IZO.CN : 0.3050 (unch)
IZOZF : 0.2213 (-0.49%)
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market

EQNX::TICKER_START (OTCQB:IZOZF),(CSE:IZO),(NASDAQ:HOLX),(NASDAQ:GEHC),(NASDAQ:NNOX),(NYSE:ORCL) EQNX::TICKER_END

IZO.CN : 0.3050 (unch)
HOLX : 74.97 (+0.15%)
IZOZF : 0.2213 (-0.49%)
GEHC : 85.46 (+3.56%)
ORCL : 217.58 (+1.52%)
NNOX : 3.64 (-4.96%)
Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT

VANCOUVER, British Columbia, and SACRAMENTO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO ) (OTCQB: IZOZF ) (FSE: 1R3 ) (“ Izotropic...

IZO.CN : 0.3050 (unch)
IZOZF : 0.2213 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. It is engaged in advancing breast cancer imaging through the commercialization of medical imaging technologies. The company's current focus is on the commercialization of its first...

See More

Key Turning Points

3rd Resistance Point 0.3217
2nd Resistance Point 0.3183
1st Resistance Point 0.3117
Last Price 0.3050
1st Support Level 0.3017
2nd Support Level 0.2983
3rd Support Level 0.2917

See More

52-Week High 0.4900
Fibonacci 61.8% 0.3162
Last Price 0.3050
Fibonacci 50% 0.2625
Fibonacci 38.2% 0.2088
52-Week Low 0.0350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar